Intelligent Ultrasound Share Price (MED)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Intelligent Ultrasound Group Plc	LSE:MED	London	Ordinary Share	GB00BN791Q39	ORD 1P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.00%	10.50	21,887	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
10.00		11.00	10.50	10.50	10.50

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Health Care Equipment & Services	5.31	-3.62	-3.59		16.0

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
15:21:33	O	18,260	10.66	GBX

Related Shares
Smith & Nephew (SN.), Nmc Health (NMC), Physiomics (PYC), Salvarx (SALV)

Intelligent Ultrasound (MED) Latest News

Intelligent Ultrasound News

Date	Time	Source	Headline
10/7/2019	11:11	ALNC	Intelligent Ultrasound Expects 25% Revenue Rise From Simulation Arm
10/7/2019	07:15	ALNCF	Alliance News Flash Headline
10/7/2019	07:00	UKREG	Intelligent Ultrasound Group PLC Trading update
04/7/2019	10:14	ALNC	Intelligent Ultrasound Secures First Contract For Imaging Software
04/7/2019	07:46	UKREG	Intelligent Ultrasound Group PLC First OEM agreement for AI based imaging..
23/5/2019	15:14	UKREG	Intelligent Ultrasound Group PLC Result of AGM
23/5/2019	12:09	ALNC	Intelligent Ultrasound Trades In Line Despite Brexit Knocking UK Sales
23/5/2019	07:00	UKREG	Intelligent Ultrasound Group PLC AGM Statement
16/5/2019	07:01	RNSNON	Intelligent Ultrasound Group PLC First live demonstration of ScanNav..
30/4/2019	07:01	UKREG	Intelligent Ultrasound Group PLC Notice of Annual General Meeting

More Intelligent Ultrasound News

Intelligent Ultrasound Takeover Rumours

Intelligent Ultrasound (MED) Share Charts

1 Year Intelligent Ultrasound Chart

1 Month Intelligent Ultrasound Chart

Intraday Intelligent Ultrasound Chart

Intelligent Ultrasound (MED) Discussions and Chat

Intelligent Ultrasound Forums and Chat

Date	Time	Title	Posts
10/7/2019	07:57	Medaphor Group PLC	75
10/7/2019	07:57	MEDAPHOR thread	9
24/10/2012	15:08	MicroEmissive Displays - LCD Replacement Technology !	787
01/12/2004	10:57	MicroEmissve Displays - LCD Replacement Technology !	-
12/2/2003	12:42	media stocks armageddon	1

Add a New Thread

Intelligent Ultrasound (MED) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
14:21:34	10.66	18,260	1,946.55	O
09:02:02	11.00	3,627	398.97	O

View all Intelligent Ultrasound trades in real-time

Intelligent Ultrasound (MED) Top Chat Posts

Date	Subject
17/7/2019 09:20	Intelligent Ultrasound Daily Update: Intelligent Ultrasound Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker MED. The last closing price for Intelligent Ultrasound was 10.50p. Intelligent Ultrasound Group Plc has a 4 week average price of 6p and a 12 week average price of 4.93p. The 1 year high share price is 19.50p while the 1 year low share price is currently 4.93p. There are currently 156,627,749 shares in issue and the average daily traded volume is 86,075 shares. The market capitalisation of Intelligent Ultrasound Group Plc is £16,445,913.65. Read Full Thread Reply
27/11/2018 16:58	tullynessle: Another Non-Regulatory RNS today https://uk.advfn.com/stock-market/london/microemissive-displays-MED/share-news/Medaphor-Group-PLC-AI-database-exceeds-1-million-i/78767501 Medaphor Group PLC AI database exceeds 1 million images 27 November 2018 MedaPhor Group plc ("MedaPhor" or the "Company") MedaPhor's AI obstetric image database exceeds 1 million images MedaPhor, the intelligent ultrasound software and simulation company, is pleased to announce that its database used for training its artificial intelligence (AI) products now exceeds 1 million obstetric ultrasound images. Large image libraries are a prerequisite to creating AI solutions. These images have helped MedaPhor to develop its ScanNav(R) AI-based clinical software for ultrasound professionals. The one million mark is a significant milestone for the Company, as it will enable it to build on its ScanNav software for the global obstetric ultrasound market. MedaPhor's ScanNav intelligent ultrasound technology, which uses AI algorithms and deep learning techniques to automatically assess ultrasound images, is currently being piloted in UK hospitals to support sonographers carrying out the 20 week anatomy scan. ScanNav assists sonographers to ensure that the images they are taking conform to the UK Fetal Anomaly Screening Programme (FASP) protocol. In future, the software will also be capable of automatically recording required images during the ultrasound scan. Continued......... Read Full Thread Follow Reply
23/11/2018 21:04	tullynessle: RNS Non-Regulatory today. https://uk.advfn.com/stock-market/london/microemissive-displays-MED/share-news/Medaphor-Group-PLC-MedaPhor-commences-clinical-tri/78750428 Medaphor Group PLC MedaPhor commences clinical trial for AnatomyGuide 23/11/2018 3:56pm RNS Non-Regulatory MedaPhor commences clinical trial for AnatomyGuide MedaPhor (AIM:MED), the intelligent ultrasound software and simulation company, announces it is commencing a clinical trial within the Aneurin Bevan University Health Board to capture data for its AnatomyGuide artificial intelligence (AI) software for ultrasound-guided anaesthetic procedures such as peripheral nerve blocks. Increasingly, ultrasound-guided peripheral nerve blocks are being used as a safer and more cost-effective alternative to general anaesthesia but not all anaesthetists have the specialist knowledge of ultrasound anatomy to perform them. AnatomyGuide provides software support and guidance to aid less experienced clinicians during the procedure. Using deep-learning techniques on a data set of thousands of real-patient images, the technology is 'taught' to recognise key anatomical structures. Then, by highlighting these structures in real-time during an ultrasound-guided nerve block procedure, AnatomyGuide's AI makes it easier for clinicians to accurately target the nerve. The clinical data from the Aneurin Bevan clinical trial is expected to complete the required data set. Through the adoption of AnatomyGuide, it is hoped that hospitals will be able to increase the number of ultrasound-guided nerve blocks that they can perform. Principal Investigator and consultant anaesthetist, Dr David Burckett-St.Laurent, said: "AnatomyGuide will help tip the balance of safety and confidence in favour of performing regional anaesthesia. I feel privileged to work with a Welsh company that is leading the world in developing AI-based ultrasound software. Our aim is to make a real clinical difference to patients by increasing the availability of regional anaesthesia through cutting edge technology. It is very exciting." AnatomyGuide is being developed as part of an Innovate UK project funded within the government's AI and data grand challenge. Nicholas Sleep, CTO at MedaPhor, commented: "AnatomyGuide shows how strategic government investment can catalyse an innovative technology that we hope will make a real difference to NHS patient care. The team in Cardiff are excited to be working with Innovate UK in developing AI technology that has real-world applications and we look forward to completing the clinical trials with David and the Aneurin Bevan University Health Board." Read Full Thread Follow Reply
21/11/2008 07:22	wild bill: From the Scotsman this morning MED calls in administrators and more technology failures feared A SCOTS company credited with developing the world's smallest television screen has become the latest victim of the global economic crisis, prompting fears that there could be a wave of business failures in the technology sector. MicroEmissive Displays is to appoint an administrator after failing to find funding to support its pioneering business. The Edinburgh-based firm, led by chief executive Bill Miller, said yesterday it had been hit by the "severe slowdown" in the demand for consumer electronics and had been unable to borrow enough cash to survive . MED, which has about 50 staff evenly split between its operations in Scotland and Dresden, Germany is continuing to trade and has not yet made any staffing cuts as a result of yesterday's announcement. In June it said it was to cut five jobs after issuing a profit warning, saying monthly profitability would be delayed until 2009. Last night technology entrepreneur and investor Ian Ritchie said he believed that , following the collapse, other struggling firms in the sector could suffer a similar fate. He said: "I think it is very likely that a lot more technology companies will fold, like in the dot com bust in 2001, when a lot of good companies were wiped out. "MicroEmissives is quite a big one and people will feel that it has gone, but there will be a lot of good smaller technology companies which will go missing without anyone noticing." Ritchie, a former board member of Scottish Enterprise, added: "It is a real shame that MicroEmissives is to go into administration. It is not a good time to be looking for emergency cash because it is just not around." The firm, listed on the Alternative Investment Market, suspended its shares following yesterday's announcement. The price before the suspension was 0.45p. A spin-out of Edinburgh and Napier universities, the company warned in September that if it did not find new financing it would run out of cash by mid-December. Last month it reported a loss of £3.8 million for the six months to 30 June an increase of £700,000 over the first half of 2007. The news is the latest in a string of blows for Scotland's technology sector. Fellow university spin-out Wolfson is battling with a plunging share price and the departure of its chief executive Dave Shrigley, as well as the loss of most of its business with iPod maker Apple. Earlier this year, listed biotech firm Ardana and dental technology company Idmos both fell into administration after a period of poor trading, while in February, Stem Cell Sciences said it was closing its headquarters in the Scottish capital in favour of its facilities in Cambridge. Adrian Smith, programme director with the Edinburgh Pre-Incubator Scheme at the University of Edinburgh, added: "I understand they have always had a problem shifting product. It's a shame because there are a lot of able people there and with a bit of luck they'll come through it, something will happen. It's discouraging for other people if they see companies having a hard time on a public market." A spokesman for MicroEmissives said the company would issue another statement once an administrator was appointed. Read Full Thread Follow Reply
30/9/2008 09:06	gninraw: The board of directors still managed to take a 7% pay rise, and the CEO took a £30000 pay rise in the last 9 months. Wonder how they managed to justify that? If they are openly saying that there "can be no certainty that a transaction will occur", then my guess is that a deal has already been done, and this is designed to trash the share price even further so that a "last minute" rescue plan seems fantastic to share holders who will welcome it with open arms......, and at a rock bottom price. Believe me when I say that these people are self serving and don't give a cr*p about share holders. Read Full Thread Follow Reply
19/9/2008 18:52	puffin tickler: According to the Finance page on Yahoo, MED currently has a market cap of £1.04m. Why would they need so much cash for a management buyout? If management want to buy the company having completely trashed the share price they will need to have the decency to pay a healthy multiple to get people to sell. Read Full Thread Follow Reply
06/9/2008 19:30	thecurrymonster: Am I the only one excited about this little gem. I think so... I got excited about them around three years ago, and I kept a close eye on the company - lots of placings and fundraisings, lots of production problems and lot's of other problems. The production problems started getting sorted about 18 months ago, and I started buying around that time, with a 12 month boom-or-bust timeframe - this was also my pick on the share comp over on TMF and one way or another, I ended up buying a lot more of these than I ever intended to! I did OK with this last year, and I top-sliced most of my holdings at over 50p - mainlybecause the share price had risen on the news of the successes of the Dresden facility rather than any definite large orders - top slicing is rarely a bad strategy anyway and as it turns out, I got lucky. I finally sold the remainder of my holding somewhere around 30p, which was around about my average buy price. Even now, the orders haven't materialised, and I'm not convinced that they ever will now - it's taken so long, that any competitive advantage must now be seriously in doubt - after all, if a company the size of Samsung SDI wants to produce microscreens then they are not going to let a tiny Scottish company get in there way, patents or no patents - quite a lot of the intellectual property belongs to Cambridge Display Technology anyway. Raising further funding in todays environment is going to be challenging unless there are big orders in the pipeline, so it looks like a buy-out of some sort is the only hope, and I can't see this coming at much of a premium to the shareprice either, so I'm not investing. I would love to see this compayt succeed and good luck to the remaining shareholders - it's still on my radar, but without any serious orders, I'm staying clear of this for now. Read Full Thread Follow Reply
15/7/2008 11:05	chocaholic: Ok, now I'm really confused. MED have recently announced that they have signed 2 MOUs. On 2 July http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=1887628&source=RNS and on 11 July http://www.londonstockexchange.com/LSECWS/IFSPages/MarketNewsPopup.aspx?id=1897106&source=RNS Yet on 2 July AXA reduced their holding from 6.425m to 2.33m shares and the share price has dropped from 14p to 8.5p. I would assume that these are the result of "discussions underway with a variety of potential customers" which "will result in significant volume orders" referred to in the Annual Report and that they are confirmation that we are on the way to month-on-month profitability during the next financial year. Obviously AXA don't share my optimism. Read Full Thread Follow Reply
17/6/2008 12:37	friars3: (1) Is it possible to find out who the major customers are, (2) When will the product be on the shelves. (3) WHAT COMPANYS ARE USING THE MICROMISSIVE EYE SET. (4) THE LATEST DEVELOPMENT WITH THE PROCUCT. THE MANAGMENT SEEM TO BE SPENDING, MOST OF THERE TIME ON THE LECTURE CIRCUIT, with little productivity from it, spending our money THE COMPANY MUST GIVE US POSITIVE NEWS keep us up dated reguarly I recall the site visit to: Dresden, Germany on the 26 July 2007, It didn't do a thing for the share price. Those selected clients had a good night out. At our expence. REMEMBER Investor Site Visit (Microemissive) RNS Number:8807A MicroEmissive Displays Group PLC 26 July 2007 For immediate release: 26 July 2007 MicroEmissive Displays Group plc ("MED" or "the Company") Investor Site Visit MED (AIM: MED.L), the AIM listed designer and manufacturer of low-power light emitting polymer displays, today announces that it is hosting a site visit for certain institutional investors at its new volume manufacturing facility in Dresden, Germany. No new material information will be disclosed during the visit. For further information, please visit www.microemissive.com or contact: Read Full Thread Follow Reply
14/3/2008 23:24	thecurrymonster: I've sold the last of my stock over the past couple of weeks or so - I'm ready to jump back in if I see a good reason to, but it seems like it is jam tomorrow with this one - there have still been no real announcements of volume orders, and without these, the company is going nowhere. It now seems that the institutions are bailing as well, and with the amount of institutional holdings here, it wouldn't take much dumping of stock to completely trash the share price. I am no longer comfortable holding this, and there are better homes for the cash in the short term IMHO. Good luck to those that still hold, I'll still be around, and MED is very much still on my RADAR - I will buy back in when there is some good news to support the share price. Read Full Thread Follow Reply
10/5/2007 10:32	unionhall: If I am reading this correctly the options require an 80% share price uplift in three years for partial exercising (30%) and 170% share price uplift for complete exercising. That certainly is a good incentive.... "The Ordinary Shares subject to LTIP awards will become exercisable in three years time subject to their continued employment and the satisfaction of share price targets (30% of the Ordinary Shares subject to LTIP awards will become exercisable if the Company's share price reaches at least #0.92 for a period of 90 trading days (30 of which must be consecutive days) during the three year period, with 100% becoming exercisable if the Company's share price reaches at least #1.38 for a period of 90 trading days (30 of which must be consecutive) during the three year period." Read Full Thread Follow Reply

Intelligent Ultrasound share price data is direct from the London Stock Exchange

Your Recent History

LSE

MED

Intelligen..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190717 20:24:47